| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/13/2005 | WO2004089958A3 Crystallization and purification of macrolides |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009872 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 01/13/2005 | US20050009823 E.g., derivatives of pyrazolo[1,5-a]pyrimidines; [1,2,3]triazolo[4,5-b]pyridines; and pyrrolo[3,2-d]pyrimidines and their use as corticotropin releasing factor antagonists |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2525580A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/12/2005 | EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents |
| 01/12/2005 | EP1495030A1 Non-steroidal progesterone receptor modulators |
| 01/12/2005 | EP1495025A1 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands |
| 01/12/2005 | EP1495007A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses |
| 01/11/2005 | CA2100924C Oxadiazine derivatives |
| 01/06/2005 | WO2004101573A9 Synthesis of substituted heterocyclic compounds |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004203 NAALADase inhibitors; effecting transforming growth factor beta or neuronal activity |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004143 Bi-cyclic pyrimidine inhibitors of TGFbeta |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004097 Indole derivatives |
| 01/06/2005 | US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 01/06/2005 | US20050002986 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 01/05/2005 | EP1493738A1 Epothilone derivatives |
| 01/05/2005 | EP1492798A1 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 01/05/2005 | EP1492797A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 01/05/2005 | EP1492796A1 Substituted amino isoxazoline derivatives and their use as anti-depressants. |
| 01/05/2005 | EP1492794A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838453 Therapy for osteoporosis |
| 12/30/2004 | US20040266861 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 12/30/2004 | US20040266765 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 12/30/2004 | US20040266703 Extraction from fermentation broth; tacrolimus |
| 12/30/2004 | DE10326386A1 N-Heterocyclyl-phenylsubstituierte cyclische Ketoenole N-heterocyclyl-substituted cyclic ketoenols |
| 12/29/2004 | WO2004113357A2 Nucleoside analog inhibitors of reverse transcriptase |
| 12/29/2004 | WO2004113330A1 Immunosuppressant compounds and compositions |
| 12/29/2004 | WO2004112699A2 Mitotic kinesin inhibitors |
| 12/29/2004 | EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects |
| 12/29/2004 | EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/29/2004 | EP1226138B1 Fab i inhibitors |
| 12/29/2004 | CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
| 12/29/2004 | CA2785950A1 New use of staurosporine derivatives |
| 12/29/2004 | CA2527533A1 Mitotic kinesin inhibitors |
| 12/29/2004 | CA2524027A1 Immunosuppressant compounds and compositions |
| 12/28/2004 | US6835860 Halogenation with iodine monochloride and iodine monobromide in an aqueous solution, forming a chemical intermediate for the preparation of indinavir, an HIV protease enzyme inhibitor |
| 12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 12/23/2004 | WO2004111042A1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 12/23/2004 | WO2004110990A2 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 12/23/2004 | WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors |
| 12/23/2004 | WO2004083215A9 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 12/23/2004 | WO2004076411A3 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 12/23/2004 | US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 12/23/2004 | US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides |
| 12/23/2004 | US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 12/23/2004 | US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/23/2004 | CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 12/23/2004 | CA2528888A1 N-heterocyclylphenyl-substituted cyclic ketoenols |
| 12/23/2004 | CA2526285A1 Inhibitors of p38 and methods of using the same |
| 12/22/2004 | EP1489418A1 Novel fluorescent label compounds |
| 12/22/2004 | EP1489187A1 Osteoclast differentiation inhibitors |
| 12/22/2004 | EP1489083A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 12/22/2004 | EP1487843A2 Substituted phenylacetic acids |
| 12/22/2004 | EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same |
| 12/22/2004 | EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 12/22/2004 | EP0987254B1 Novel cyclic diamine compounds and medicine containing the same |
| 12/22/2004 | CN1556804A 3-substituted-4-pyrimidone derivatives |
| 12/22/2004 | CN1556706A Thieno [1,3] oxazin-4-ones with lipase inhibiting activity |
| 12/22/2004 | CN1180774C Use of rapamycin for preparing medicine for treating cardiac inflammatory disease |
| 12/21/2004 | US6833382 Streptogramins and method for preparing same by mutasynthesis |
| 12/21/2004 | US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin |
| 12/16/2004 | WO2004108722A1 Orthocondensed polycyclic aminopyrrole derivatives comprising an electro-attractive substituent, combination products of said derivatives, and method for the production thereof |
| 12/16/2004 | WO2004108133A2 Modulators of vr1 receptor |
| 12/16/2004 | WO2004085442A3 New calix arene compounds, their process of preparation and their use, particularly as enzymatic mimes |
| 12/16/2004 | WO2003090684A8 Polymer compositions containing a macrocyclic triene compound |
| 12/16/2004 | US20040254376 Cyclic amidine derivative |
| 12/16/2004 | US20040254372 Poly(adenosine 5'-diphospho-ribose)polymerase (PARP) inhibitor; for treating or preventing neurological, genetic, autoimmune, nervous system, cardiovascular disorders, cancer; such as myocardial infarction, angina pectoris and cardiogenic shock |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254163 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
| 12/16/2004 | US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression |
| 12/15/2004 | EP1486500A1 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium |
| 12/15/2004 | EP1485369A1 Blue 3h-naphtho- 2,1-b]-pyran derivatives and use thereof |
| 12/15/2004 | EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS |
| 12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
| 12/15/2004 | CN1555367A 3-substituted-4-pyrimidone derivatives |
| 12/15/2004 | CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier |
| 12/15/2004 | CN1179945C Indole derivatives, process for preparation of same and use thereof |
| 12/14/2004 | US6831087 2-(Pyrid-2- or 4-yl)-1,2,3,4-tetrahydroisoquinoline and derivatives; a good affinity to the NMDA receptor (N-methyl-D-asparate); acute/cronic neurodegenerative diseases; bacterial/viral infections; antidepressants; analgesics |
| 12/11/2004 | CA2431560A1 Derivatives of streptogramins, their preparation and compositions containing them |
| 12/09/2004 | WO2004106492A2 Bicyclicpyrimidones and their use to treat diseases |
| 12/09/2004 | WO2004106385A2 Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 12/09/2004 | WO2004106346A1 Indole derivatives with an improved antipsychotic activity |
| 12/09/2004 | WO2004106298A1 Indole derivatives with an improved antipsychotic activity |
| 12/09/2004 | WO2004106293A2 Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| 12/09/2004 | WO2004105765A1 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 12/09/2004 | US20040248904 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 12/09/2004 | US20040248893 Isoxazolopyridinones |